diabetic retinopathy

Displaying 5 studies

  • Treatment for CI-DME in Eyes With Very Good VA Study Rochester, MN

    Although multiple studies have clearly demonstrated that ranibizumab therapy is more effective than laser alone for vision gain and avoiding vision loss in patients with central-involved Diabetic Macular Edema (DME), only eyes with poor visual acuity, such as a visual acuity letter score of 78 or worse (approximate Snellen equivalent of 20/32 or worse) were eligible. Eyes that have central-involved DME with "good" visual acuity (20/25 or better) have not been addressed systematically by recent studies for treatment of DME. Baseline cohort characteristics from the Early Treatment Diabetic Retinopathy Study (ETDRS) suggest that a substantial percentage of eyes with central-involved ...

  • A Study to Learn More About the Eye (Intraocular Pressure, Ocular Hemodynamics) After Intravitreal Injections Rochester, MN

    The purpose of this study is to find out how much the eye pressure increases after giving the injection, and what happens to the blood supply of the various parts of the eye.

  • Determinants of Diabetic Nephropathy in American Indians Scottsdale/Phoenix, AZ; Rochester, MN

    The purpose of this study is to examine the evolution of diabetic kindey injury over an extended period in a group of subjects who previously completed a clinical trial which assessed the ability of losartan to protect the kidney from injury in early diabetic kidney disease. We will also explore the relationship between diabetic kidney disease and other diabetes complications, including neuropathy and retinopathy.

  • Anti-VEGF vs. Prompt Vitrectomy for VH From PDR Rochester, MN

    Although vitreous hemorrhage (VH) from proliferative diabetic retinopathy (PDR) can cause acute and dramatic vision loss for patients with diabetes, there is no current, evidence-based clinical guidance as to what treatment method is most likely to provide the best visual outcomes once intervention is desired. Intravitreous anti-vascular endothelial growth factor (anti-VEGF) therapy alone or vitrectomy combined with intraoperative PRP each provide the opportunity to stabilize or regress retinal neovascularization. However, clinical trials are lacking to elucidate the relative time frame of visual recovery or final visual outcome in prompt vitrectomy compared with initial anti-VEGF treatment. The Diabetic Retinopathy Clinical Research ...

  • A Study to Assess Screening for Diabetic Retinopathy Using Retinal Camera in Family Medicine Clinic Jacksonville, FL

    The purpose of this study is to evaluate the ability of appropriately-trained family physicians to screen for and identify Diabetic Retinopathy using retinal camera and, secondarily, to describe patients’ perception of the convenience and cost-effectiveness of retinal imaging.


Mayo Clinic Footer